NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . April 6th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

Cancer Vaccines - Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data

HIV/AIDS - Data from A. Fernandezgarcia et al provide new insights into HIV/AIDS

HIV/AIDS - Reports from University of Cape Town describe recent advances in HIV/AIDS

HIV/AIDS - Research from Centers for Disease Control and Prevention yields new findings on HIV/AIDS

HIV/AIDS - Research on HIV/AIDS described by scientists at Johns Hopkins University

HIV/AIDS - Scientists at Baylor College of Medicine, College of Medicine report research in HIV/AIDS

HIV/AIDS Co-Infection - Research on HIV/AIDS co-infection published by scientists at Emory University

Aphios Corporation - Aphios Corporation Executes Collaborative R&D Agreement with VivaCell Biotechnology Espana to Develop Combination Therapy for HIV Latency

Cancer Vaccines - ImQuest Presentations at Keystone Symposium Focus on Advancements in Their Therapeutic and Microbicide Development Programs



Return to Top of Page

-----------------------
PR Login